Loading...
XASE
MLSS
Market cap50mUSD
Jul 22, Last price  
0.64USD
1D
1.78%
1Q
-30.68%
Jan 2017
-54.20%
Name

Milestone Scientific Inc

Chart & Performance

D1W1MN
P/E
P/S
5.12
EPS
Div Yield, %
Shrs. gr., 5y
15.57%
Rev. gr., 5y
0.42%
Revenues
10m
+11.60%
4,751,1866,433,1485,844,1776,390,7136,623,8078,549,0609,749,9688,378,0948,648,24210,011,42010,333,0909,491,56910,482,00511,281,8869,622,0768,374,5015,437,23610,304,7118,805,9069,827,444
Net income
-7m
L-20.41%
-2,996,864-2,754,227-3,152,268-2,938,696-1,187,454-1,530,085-614,508-1,482,100-870,3061,464,930-1,702,024-5,467,522-5,946,507-5,186,793-7,431,645-7,661,564-7,486,699-7,119,021-8,706,131-6,929,104
CFO
-5m
L-11.70%
-4,284,869-3,266,317-1,650,718-1,150,670-442,006402,951-293,777-570,730-49,7181,258,736376,943-2,946,338-5,398,581-1,229,434-1,628,106-1,779,288-6,984,928-4,017,581-6,031,996-5,326,129
Earnings
Aug 13, 2025

Profile

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
IPO date
Nov 03, 1995
Employees
20
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
9,827
11.60%
8,806
-14.54%
Cost of revenue
3,736
5,055
Unusual Expense (Income)
NOPBT
6,091
3,751
NOPBT Margin
61.98%
42.59%
Operating Taxes
(67)
Tax Rate
NOPAT
6,091
3,817
Net income
(6,929)
-20.41%
(8,706)
22.29%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,570
BB yield
-5.12%
Debt
Debt current
227
101
Long-term debt
678
893
Deferred revenue
Other long-term liabilities
Net debt
(5,049)
(7,721)
Cash flow
Cash from operating activities
(5,326)
(6,032)
CAPEX
(5)
(9)
Cash from investing activities
(2,972)
(9)
Cash from financing activities
2,561
(9)
FCF
4,206
3,912
Balance
Cash
5,954
8,715
Long term investments
Excess cash
5,463
8,275
Stockholders' equity
(123,050)
(116,560)
Invested Capital
131,572
127,064
ROIC
4.71%
3.03%
ROCE
71.48%
35.71%
EV
Common stock shares outstanding
72,776
70,607
Price
0.69
43.73%
0.48
-76.70%
Market cap
50,208
48.14%
33,892
-76.10%
EV
45,373
25,951
EBITDA
6,242
3,895
EV/EBITDA
7.27
6.66
Interest
55
Interest/NOPBT
1.46%